Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5271501
Max Phase: Preclinical
Molecular Formula: C19H26N2O2
Molecular Weight: 314.43
Associated Items:
ID: ALA5271501
Max Phase: Preclinical
Molecular Formula: C19H26N2O2
Molecular Weight: 314.43
Associated Items:
Canonical SMILES: CC12CN3CC(C)(CN(C1)C3C1=CC(=O)[C@H]3C[C@@H]1C3(C)C)C2=O
Standard InChI: InChI=1S/C19H26N2O2/c1-17(2)12-6-13(17)14(22)5-11(12)15-20-7-18(3)8-21(15)10-19(4,9-20)16(18)23/h5,12-13,15H,6-10H2,1-4H3/t12-,13+,15?,18?,19?/m0/s1
Standard InChI Key: OUGZNEFXXKBMDR-VXRSPYDMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 314.43 | Molecular Weight (Monoisotopic): 314.1994 | AlogP: 1.71 | #Rotatable Bonds: 1 |
Polar Surface Area: 40.62 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.67 | CX LogP: 2.67 | CX LogD: 2.66 |
Aromatic Rings: 0 | Heavy Atoms: 23 | QED Weighted: 0.74 | Np Likeness Score: 1.06 |
1. Suslov E, Zarubaev VV, Slita AV, Ponomarev K, Korchagina D, Ayine-Tora DM, Reynisson J, Volcho K, Salakhutdinov N.. (2017) Anti-influenza activity of diazaadamantanes combined with monoterpene moieties., 27 (19): [PMID:28886889] [10.1016/j.bmcl.2017.08.062] |
Source(1):